Neurological Sciences

, Volume 34, Issue 5, pp 689–693 | Cite as

Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease

  • Mohammad Rohani
  • Arash Sefidkar Langroodi
  • Shadi Ghourchian
  • Khalil Ghasemi Falavarjani
  • Reza SoUdi
  • Gholamali Shahidi
Original Article


Parkinson disease is a multisystem neurodegenerative disease which involves not only basal ganglia and extrapyramidal system but also many other neurologic systems such as retinal ganglion cells. Optical coherence tomography (OCT) is a non-invasive method for assessment of retinal nerve fiber layer (RNFL) thickness and its changes in different diseases. To evaluate the RNFL thickness in patients with Parkinson disease (PD), we performed OCT in patients with PD and compared it with a control group. From October 2010 to July 2011, 27 PD patients (54 eyes) and 25 healthy persons (50 eyes) were entered to this analytical cross-sectional study according to the defined criteria. PD patients were categorized into two groups “akinetic rigid (AR) and tremor dominant (TD)”. RNFL was divided into four quadrants and was assessed by OCT. Afterwards; the data were analyzed by bivariate and multivariate models. The RNFL thickness in PD was significantly lower than the control group. Also, the thicknesses of inferior and nasal quadrants of RNFL in TD group were significantly more than AR group. According to these findings, OCT can be used as a sensitive and objective marker for assessment of early neurodegenerative changes of PD and early initiation of neuroprotective treatments. Future studies with adequate sample sizes are recommended to investigate interactions between age, distribution of the disease and type of PD as well as the effects of individual factors.


Retinal nerve fiber layer Akinetic rigid (AR) Parkinson’s disease Tremor dominant (TD) Parkinson’s disease Parkinson disease (PD) Optic coherence tomography (OCT) 


  1. 1.
    Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37:3509–3529PubMedCrossRefGoogle Scholar
  2. 2.
    Korell M, Tanner C (2005) Epidemiology of Parkinson’s disease. In: Ebadi M, Pfeiffer R (eds) Parkinson’s disease. CRC Press, New York, pp 39–50Google Scholar
  3. 3.
    Braak H, Del Tredici K, Bratzke H et al (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249:1–5CrossRefGoogle Scholar
  4. 4.
    Bodis-Wollner I (2002) Visualizing the next steps in Parkinson disease. Arch Neurol 59:1233–1234PubMedCrossRefGoogle Scholar
  5. 5.
    Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson’s disease. Arch Neurol 59:1249–1252PubMedCrossRefGoogle Scholar
  6. 6.
    Hajee ME et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737–741PubMedCrossRefGoogle Scholar
  7. 7.
    Altintas O (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116:137–146PubMedCrossRefGoogle Scholar
  8. 8.
    Bodis-Wollner Ivan (2009) Retinopathy in Parkinson disease. J Neural Transm 116:1493–1501PubMedCrossRefGoogle Scholar
  9. 9.
    Inzelberg R, Ramirez JA, Niisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797PubMedCrossRefGoogle Scholar
  10. 10.
    Parisi V, Manni G, Sparado M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthal Vis Sci 40:2520–2527PubMedGoogle Scholar
  11. 11.
    Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of glaucomatous damage of retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 135:513–520PubMedCrossRefGoogle Scholar
  12. 12.
    Hughes AJ et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRefGoogle Scholar
  13. 13.
    Lewis SJ, Foltynie T, Blackwell AD et al (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCrossRefGoogle Scholar
  14. 14.
    Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson_s disease. Invest Ophthal Vis Sci 31:2473–2475PubMedGoogle Scholar
  15. 15.
    Onofrj M, Bodis-Wollner I (1982) Dopaminergic deficiency causes delayed VEPs in rats. Ann Neurol 11:484–490PubMedCrossRefGoogle Scholar
  16. 16.
    Masson G, Mestre D, Blin O (1993) Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 7(8):449–463PubMedCrossRefGoogle Scholar
  17. 17.
    Nowacka B, Lubiński W, Karczewicz D (2010) Ophthalmological and electrophysiological features of Parkinson’s disease. Klin Oczna 112(7–9):247–252PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Mohammad Rohani
    • 1
  • Arash Sefidkar Langroodi
    • 1
  • Shadi Ghourchian
    • 2
  • Khalil Ghasemi Falavarjani
    • 3
  • Reza SoUdi
    • 3
  • Gholamali Shahidi
    • 1
  1. 1.Department of NeurologyTehran University of Medical SciencesTehranIran
  2. 2.Students’ Scientific Research CenterTehran University of Medical SciencesTehranIran
  3. 3.Department of OphthalmologyTehran University of Medical SciencesTehranIran

Personalised recommendations